Business Context and Reporting Period
Company: Nano Dimension Ltd.
Filing Type: Form 8-K (Current Report)
Date of Report: February 2, 2026
Reporting Period: Event-based (February 2, 2026)
Business Context: The Company, incorporated in Israel with principal offices in Waltham, MA, entered into a Rights Agreement with The Bank of New York Mellon to implement a stockholder rights plan (poison pill) designed to protect the interests of ADS holders against unsolicited acquisition attempts.
Key Financial Metrics
This filing is a Current Report on Form 8-K regarding a corporate governance action and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial performance metrics.
Material Changes Versus Prior Period
There are no financial material changes reported in this filing. The material change is the adoption of a new defensive corporate structure:
- Implementation of Rights Plan: Issuance of one special purchase right (Right) for each outstanding American Depositary Share (ADS).
- Trigger Threshold: The plan is triggered if any person or group acquires beneficial ownership of 9.99% or more of the Company's Ordinary Shares (an "Acquiring Person").
- Dilution Mechanism: Upon triggering, holders of Rights (excluding the Acquiring Person) may purchase one ADS for $0.01, causing substantial dilution to the Acquiring Person.
Guidance, Outlook, and Management Commentary
Management Commentary: The Board of Directors believes the Rights Agreement is an effective course of action to fulfill fiduciary duties and enable ADS holders to realize long-term value. The plan is intended to ensure the Board has sufficient time to make informed judgments regarding attempts to control the Company and to encourage potential acquirers to negotiate directly with the Board.
Key Terms and Contingencies:
- Exercisability: Rights become exercisable 10 days after the public announcement of an Acquiring Person or a tender offer that would result in one.
- Redemption: The Board may redeem the Rights for no consideration at any time prior to the emergence of an Acquiring Person.
- Expiration: The Rights will expire on February 1, 2027.
- Amendments: The Board may amend the agreement without holder consent prior to the emergence of an Acquiring Person; thereafter, amendments cannot adversely affect holders.
- Exchange: After an Acquiring Person emerges, the Board may exchange Rights for ADSs at a 1:1 ratio, provided no person owns 50% or more of the outstanding shares.
Risks: The primary risk addressed is hostile takeover or significant influence without Board approval. The plan creates a significant dilution risk for any entity crossing the 9.99% ownership threshold without Board approval.
Important Facts for Investor Verification
- Verify the current beneficial ownership percentages of major shareholders to assess proximity to the 9.99% trigger threshold.
- Confirm the exact number of outstanding ADSs as of the record date (February 13, 2026) to understand the total number of Rights issued.
- Monitor for any Board announcements regarding the redemption of the Rights prior to any potential acquisition attempt.
- Note the expiration date of the Rights Plan is February 1, 2027.
- Review the full text of the Rights Agreement (Exhibit 4.1) for specific exceptions to the "Acquiring Person" definition, such as Permitted Offers.